Mitochondrial dysfunction and mitophagy in fuchs endothelial corneal dystrophy

32Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Fuchs endothelial corneal dystrophy (FECD) is a genetically complex, heterogenous, agerelated degenerative disease of corneal endothelial cells (CEnCs), occurring in the fifth decade of life with a higher incidence in females. It is characterized by extracellular matrix (ECM) protein deposition called corneal guttae, causing light glare and visual complaints in patients. Corneal transplantation is the only treatment option for FECD patients, which imposes a substantial socioeconomic burden. In FECD, CEnCs exhibit stress-induced senescence, oxidative stress, DNA damage, heightened reactive oxygen species (ROS) production, mitochondrial damage, and dysfunction as well as sustained endoplasmic reticulum (ER) stress. Among all of these, mitochondrial dysfunction involving altered mitochondrial bioenergetics and dynamics plays a critical role in FECD pathogenesis. Extreme stress initiates mitochondrial damage, leading to activation of autophagy, which involves clearance of damaged mitochondria called auto(mito)phagy. In this review, we discuss the role of mitochondrial dysfunction and mitophagy in FECD. This will provide insights into a novel mechanism of mitophagy in post-mitotic ocular cell loss and help us explore the potential treatment options for FECD.

Cite

CITATION STYLE

APA

Kumar, V., & Jurkunas, U. V. (2021, August 1). Mitochondrial dysfunction and mitophagy in fuchs endothelial corneal dystrophy. Cells. MDPI. https://doi.org/10.3390/cells10081888

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free